These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10604825)

  • 21. Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure.
    Indjova D; Kassabova L; Svinarov D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):327-30. PubMed ID: 15687002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical equations to calculate true mycophenolic acid concentration in human plasma by using two immunoassays with different cross-reactivities with acyl glucuronide metabolite: comparison of calculated values with values obtained by using an HPLC-UV method.
    Dasgupta A; Johnson M; Tso G
    J Clin Lab Anal; 2013 Jul; 27(4):290-3. PubMed ID: 23852786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
    Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry.
    Patel CG; Mendonza AE; Akhlaghi F; Majid O; Trull AK; Lee T; Holt DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):287-94. PubMed ID: 15556544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation.
    Brunet M; Oppenheimer F; Martorell J; Vilardell J; Carreño MC; Carrillo M; Corbella J
    Transplant Proc; 1999 Sep; 31(6):2275-6. PubMed ID: 10500574
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma.
    Rebollo N; Calvo MV; Martín-Suárez A; Domínguez-Gil A
    Clin Biochem; 2011 Feb; 44(2-3):260-3. PubMed ID: 20923675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
    Bolon M; Jeanpierre L; El Barkil M; Chelbi K; Sauviat M; Boulieu R
    J Pharm Biomed Anal; 2004 Nov; 36(3):649-51. PubMed ID: 15522544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection.
    Atcheson B; Taylor PJ; Mudge DW; Johnson DW; Pillans PI; Tett SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):157-63. PubMed ID: 14659448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma.
    Zivanović L; Protić A; Zecević M; Jocić B; Kostić M
    J Pharm Biomed Anal; 2009 Nov; 50(4):640-8. PubMed ID: 19036547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between MPA free fraction and free MPAG concentrations in heart transplant recipients based on simultaneous HPLC quantification of the target compounds in human plasma.
    Cussonneau X; Bolon-Larger M; Prunet-Spano C; Bastien O; Boulieu R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):674-8. PubMed ID: 17350903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
    Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
    Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine.
    Yau WP; Vathsala A; Lou HX; Chan E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):101-12. PubMed ID: 15113545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies.
    Bahrami G; Mohammadi B
    Clin Chim Acta; 2006 Aug; 370(1-2):185-90. PubMed ID: 16707117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.
    de Loor H; Naesens M; Verbeke K; Vanrenterghem Y; Kuypers DR
    Clin Chim Acta; 2008 Mar; 389(1-2):87-92. PubMed ID: 18157945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.